Fetal echogenic bowel

By trimester

Weeks 1–13

1st trimester

Echogenic bowel is primarily a second-trimester ultrasound finding. First-trimester context still matters because prior cell-free DNA or serum screening changes the aneuploidy discussion, and prior cystic-fibrosis carrier screening may determine whether the other genetic parent needs screening.

Weeks 14–27

2nd trimester

Confirm that the bowel brightness is at least equal to surrounding bone on appropriate ultrasound settings and whether the finding is isolated after a detailed anatomy survey. Current specialist guidance calls for cystic-fibrosis and fetal CMV evaluation. Negative prior aneuploidy screening generally means no further chromosome assessment solely for isolated echogenic bowel.

Weeks 28–birth

3rd trimester

A third-trimester ultrasound is recommended to reassess the bowel and fetal growth even when the earlier finding was isolated. Resolution is common, but growth restriction, bowel dilation, abnormal fluid, or a new structural finding changes counseling and may require maternal-fetal medicine, genetics, neonatal, or pediatric-surgery planning.

What does the evidence show for fetal echogenic bowel?

• Echogenic bowel is bowel with brightness equal to or greater than nearby bone. The ultrasound assessment is subjective and can be exaggerated by high-frequency transducers or high gain, so confirming technique and the presence of other findings is an important first step. 1
• SMFM recommends cystic-fibrosis and fetal cytomegalovirus evaluation plus a third-trimester ultrasound for reassessment and growth after isolated echogenic bowel. If prior serum or cell-free DNA screening is negative, it recommends no additional aneuploidy assessment solely because of this isolated marker. 2
• A systematic review of 25 studies including 12,971 fetuses with isolated echogenic bowel reported chromosomal anomalies in 3.3%, cystic fibrosis in 2.2%, and congenital infection in 2.2%, mainly CMV. Most findings regressed, but study designs and workups varied and pooled frequencies are not an individual prediction. 3
• In a retrospective cohort of 64,048 singleton pregnancies, echogenic bowel was associated with higher rates of fetal growth restriction and fetal death even after excluding aneuploidy and CMV cases. The association persisted in isolated cases, but the older single-center design cannot establish causation or today's absolute risk. 4
• Possible explanations for echogenic bowel include normal variation, swallowed blood after intra-amniotic bleeding, congenital infection, cystic fibrosis-related thick meconium, aneuploidy, bowel obstruction, and placental insufficiency. Ultrasound appearance alone does not identify which explanation applies. 5

When should I call my provider about fetal echogenic bowel?

Fetal echogenic bowel itself causes no maternal symptom. Promptly contact the obstetric team if the report also lists growth restriction, bowel dilation, abnormal fluid, another structural anomaly, or an abnormal genetic or infection result, because the finding is no longer isolated. Seek urgent obstetric care for vaginal bleeding beyond spotting, fluid leakage, severe persistent abdominal pain, or fetal movement that slows or stops. When in doubt, call your obstetric team the same day. Early input almost always beats waiting, and the on-call line exists exactly for this.